160 related articles for article (PubMed ID: 34252090)
21. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
[TBL] [Abstract][Full Text] [Related]
22. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
[TBL] [Abstract][Full Text] [Related]
23. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.
Claxton K; Martin S; Soares M; Rice N; Spackman E; Hinde S; Devlin N; Smith PC; Sculpher M
Health Technol Assess; 2015 Feb; 19(14):1-503, v-vi. PubMed ID: 25692211
[TBL] [Abstract][Full Text] [Related]
24. Should colorectal cancer screening start at different ages for men and women? Cost-effectiveness analysis for a resource-constrained service.
Thomas C; Mandrik O; Whyte S; Saunders CL; Griffin SJ; Usher-Smith JA
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1344. PubMed ID: 33533190
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer.
Pil L; Fobelets M; Putman K; Trybou J; Annemans L
Eur J Intern Med; 2016 Jul; 32():72-8. PubMed ID: 27157827
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant Statin Therapy for Esophageal Adenocarcinoma: A Cost-Utility Analysis.
Fong Soe Khioe R; Skedgel C; Hart A; Lewis MPN; Alexandre L
Pharmacoeconomics; 2018 Mar; 36(3):349-358. PubMed ID: 29210031
[TBL] [Abstract][Full Text] [Related]
27. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness of Screening, Surveillance, and Endoscopic Eradication Therapies for Managing the Burden of Esophageal Adenocarcinoma.
Rubenstein JH; Inadomi JM
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):77-90. PubMed ID: 33213801
[TBL] [Abstract][Full Text] [Related]
29. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
Mohan G; Chattopadhyay S
JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
[TBL] [Abstract][Full Text] [Related]
31. The Cost Effectiveness of Docetaxel and Active Symptom Control versus Active Symptom Control Alone for Refractory Oesophagogastric Adenocarcinoma: Economic Analysis of the COUGAR-02 Trial.
Meads DM; Marshall A; Hulme CT; Dunn JA; Ford HE
Pharmacoeconomics; 2016 Jan; 34(1):33-42. PubMed ID: 26340940
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
Ladabaum U; Mannalithara A; Mitani A; Desai M
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524
[TBL] [Abstract][Full Text] [Related]
33. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.
Nayak S; Roberts MS; Greenspan SL
Ann Intern Med; 2011 Dec; 155(11):751-61. PubMed ID: 22147714
[TBL] [Abstract][Full Text] [Related]
35. Cost-Effectiveness of Melanoma Screening in Inflammatory Bowel Disease.
Anderson AJM; Ferris LK; Binion DG; Smith KJ
Dig Dis Sci; 2018 Oct; 63(10):2564-2572. PubMed ID: 29948569
[TBL] [Abstract][Full Text] [Related]
36. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness of Cancer Screening: Health and Costs in Life Years Gained.
Ratushnyak S; Hoogendoorn M; van Baal PHM
Am J Prev Med; 2019 Dec; 57(6):792-799. PubMed ID: 31753260
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of CT screening in the National Lung Screening Trial.
Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review.
Ran T; Cheng CY; Misselwitz B; Brenner H; Ubels J; Schlander M
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1969-1981.e15. PubMed ID: 30659991
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of the Norwegian breast cancer screening program.
van Luijt PA; Heijnsdijk EA; de Koning HJ
Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
